Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q1 EPS of ($0.62), $0.12 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $10 million versus the consensus estimate of $111.11 thousand.

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Morgan Stanley upgrades CDW on stronger AI-driven server demand